Karin Schölin Bywall (K Schölin Bywall, K Schölin Bywall)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Rheumatoid Arthritis

Ankylosing Spondylitis

Decision Making

Disease Activity

Top Venues

Medical decision making : an international journal of the Society for Medical Decision Making

Scandinavian journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Rachael L DiSantostefano, G Simons, M Englbrecht, Jennifer H Humphreys, Ian N Bruce, Karin Schölin Bywall, C Radawski, K Raza, Marie Falahee, Jorien Veldwijk
Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis. Medical decision making : an international journal of the Society for Medical Decision Making 44 (2) (2024)
Rachael L DiSantostefano, G Simons, M Englbrecht, Jennifer H Humphreys, Ian N Bruce, Karin Schölin Bywall, C Radawski, K Raza, Marie Falahee, Jorien Veldwijk
Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis. Medical decision making : an international journal of the Society for Medical Decision Making (2024)
Rachael L DiSantostefano, G Simons, M Englbrecht, Jennifer H Humphreys, Ian N Bruce, Karin Schölin Bywall, C Radawski, K Raza, Marie Falahee, Jorien Veldwijk
Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis. Medical decision making : an international journal of the Society for Medical Decision Making 44 (2) (2024)
Rachael L DiSantostefano, G Simons, M Englbrecht, Jennifer H Humphreys, Ian N Bruce, Karin Schölin Bywall, C Radawski, K Raza, Marie Falahee, Jorien Veldwijk
Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis. Medical decision making : an international journal of the Society for Medical Decision Making 44 (2) (2024)
Karin Schölin Bywall, Bente Appel Esbensen, Marie Heidenvall, Inger Erlandsson, Marta Lason, Mats Hansson, Jennifer Viberg Johansson
Physical function and severe side effects matter most to patients with RA (< 5 years): a discrete choice experiment assessing preferences for personalized RA treatment. BMC rheumatology 7 (1) (2023)
Gwenda Simons, Karin Schölin Bywall, Matthias Englbrecht, E C Johansson, Rachael L DiSantostefano, Christine A Radawski, Jorien Veldwijk, Karim Raza, Marie Falahee
Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis. Scandinavian journal of rheumatology (2022)
Karin Schölin Bywall, Jennifer Viberg Johansson, Inger Erlandsson, Marie Heidenvall, Marta Lason, Bente Appel Esbensen
Making space for patients' preferences in precision medicine: a qualitative study exploring perspectives of patients with rheumatoid arthritis. BMJ open 12 (6) (2022)
Karin Schölin Bywall, Bente Appel Esbensen, Marta Lason, Marie Heidenvall, Inger Erlandsson, Jennifer Viberg Johansson
Functional capacity vs side effects: treatment attributes to consider when individualising treatment for patients with rheumatoid arthritis. Clinical rheumatology (2021)
Karin Schölin Bywall, Jorien Veldwijk, Mats G Hansson, Ulrik Kihlbom
Patient Perspectives on the Value of Patient Preference Information in Regulatory Decision Making: A Qualitative Study in Swedish Patients with Rheumatoid Arthritis. The patient 12 (3) (2020)
Karin Schölin Bywall, Ulrik Kihlbom, Mats Hansson, Marie Falahee, Karim Raza, Eva Baecklund, Jorien Veldwijk
Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients. Arthritis research & therapy 22 (1) (2020)